Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%
Status:
Withdrawn
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase I, open-label, parallel trial to evaluate Pharmacokinetics, Pharmacodynamics
and Safety of Testosterone gel 1% for topic usage in post-menopausal women, for 28 days